Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria

African Health Sciences

Volumn 12, Issue 3, 2012, Pages 312-317

  Tremeau Bravard, A ^a   Ogbukagu, I C ^a   Ticao, C J ^a   Abubakar, J J ^a  

^a Gede Foundation   (Nigeria)

Author keywords

Cohort study; Hepatitis b virus; Hepatitis c virus; Human immunodeficiency virus; Nigeria

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIXED INFECTION; NIGERIA; RETROSPECTIVE STUDY; SEROPREVALENCE; SEX DIFFERENCE;

COHORT STUDY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; NIGERIA;

ADULT; AGE DISTRIBUTION; AGED; CD4 LYMPHOCYTE COUNT; COINFECTION; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84872463891     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v12i3.10     Document Type: Article

References (26)

1. WHO-HIV/AIDS [database on the Internet]. World Health Organization. 2011 [cited 2011 Jul]. Available from: http://www.who.int/gho/hiv/en/.
2. CIA-The World Factbook [database on the Internet]. Washington, DC: Central Intelligence Agency. 2009 [cited 2011 Jul 23]. Available from: https://www.cia.gov/library/publications/theworld-factbook/.
3. WHO-Hepatitis B [database on the Internet]. World Health Organization. 2008 Aug [cited 2011 Jul]. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/index.html.
4. WHO-Hepatitis C [database on the Internet]. World Health Organization. 2011 Jun [cited 2011 Jul]. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/index.html.
5. Modi AA, Feld JJ. Viral hepatitis and HIV in Africa. AIDS Rev. 2007 Jan-Mar;9(1):25-39.
6. Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub- Saharan Africa. Lancet Infect Dis. 2002 May;2(5):293-302.
7. Mendes-Correa M, Nunez M. Management of HIV and hepatitis virus coinfection. Expert Opin Pharmacother. 2010 Oct;11(15):2497-2516.
8. Kumar R, Singla V, Kacharya S. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Trop Gastroenterol. 2008 Jul-Sep;29(3):136-147.
9. WHO-Scaling up antiretroviral therapy in resourcelimited settings [database on the Internet]. World Health Organization. 2003 [cited 2011 Oct]. Available from: http://www.who.int/3by5/publications/documents/arv_guidelines/en.
10. Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, et al. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol. 2008 Apr-Jun;7(2):152-156.
11. Adewole OO, Anteyi E, Ajuwon Z, Wada I, Elegba F, Ahmed P, et al. Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries. 2009;3(5):369-375.
12. Ogbuji QC, Oke AE. Quality of life among persons living with HIV infection in Ibadan, Nigeria. Afr J Med Med Sci. 2010 Jun;39(2):127-135.
13. Aliyu MH, Varkey P, Salihu HM, Iliyasu Z, Abubakar IS. The HIV/AIDS epidemic in Nigeria: progress, problems and prospects. Afr J Med Med Sci. 2010 Sep;39(3):233-239.
14. Forbi JC, Gabadi S, Alabi R, Iperepolu HO, Pam CR, Entonu PE, et al. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. Mem Inst Oswaldo Cruz. 2007 Jun;102(4):535-537.
15. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz. 2005 Feb;100(1):13-16.
16. Nigeria Common Country Assessment [database on the Internet]. World Health Organization. 2001 [cited 2012 Feb]. Available from: www.ng.undp.org/documents/CCA_2001.pdf.
17. National Population Commission (NPC) and ICF Macro. 2009 Nigeria demographic and health survey 2008: key findings. Calverton, MD: NPC and ICF Macro. [Cited 2011 Jul]. Available from: www.measuredhs.com/pubs/pdf/SR173/SR173.pdf.
18. Lesi OA, Kehinde MO, Oguh DN, Amira CO. Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. Niger Postgrad Med J. 2007 Jun;14(2):129-133.
19. Adesina O, Oladokun A, Akinyemi O, Adedokun B, Awolude O, Odaibo G, et al. Human immuno-deficiency virus and hepatitis B virus coinfection in pregnancy at the University College Hospital, Ibadan. Afr J Med Med Sci. 2010 Dec;39(4):305-310.
20. Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, et al. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis. 2009 Oct 15;49(8):1268-1273.
21. Nwokedi EO, Odimayo MS, Emokpae AM, Yahaya IA, Sadiq MN, Okwori EE. Seroprevalence of hepatitis B surface antigen among patients attending Aminu Kano Teaching Hospital, Kano. Niger J Med. 2010 Oct-Dec;19(4):423-426.
22. Koate BB, Buseri FI, Jeremiah ZA. Seroprevalence of hepatitis C virus among blood donors in Rivers State, Nigeria. Transfus Med. 2005 Oct;15(5):449-451.
23. Monga HK, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M, et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis. 2001 Jul 15;33(2):240-247.
24. Chen TY, Ding EL, Seage Iii GR, Kim AY. Metaanalysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis. 2009 Nov 15;49(10):1605-1615.
25. Diop-Ndiaye H, Toure-Kane C, Etard JF, Lo G, Diaw P, Ngom-Gueye NF, et al. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). J Med Virol. 2008 Aug;80(8):1332-1336.
26. Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet. 2011 Apr 2;377(9772):1198-1209.